Nasus Pharma Ltd (NSRX) › Cash & EquivalentsNasus Pharma Ltd (NSRX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $193.0K2024: $284.0K2025: $1.24M$1.24M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.24M+335.6%2024$284.0K+47.2%2023$193.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share